Success and Failure of Cardiovascular Disease Prevention in Czech Republic Over the Past 30 Years. Czech Part of the EUROASPIRE I-IV Surveys

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10366047" target="_blank" >RIV/00216208:11110/17:10366047 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11140/17:10366047 RIV/00669806:_____/17:10366047 RIV/00064190:_____/17:N0000086

Result on the web

<a href="http://www.biomed.cas.cz/physiolres/pdf/2017/66_S77.pdf" target="_blank" >http://www.biomed.cas.cz/physiolres/pdf/2017/66_S77.pdf</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Success and Failure of Cardiovascular Disease Prevention in Czech Republic Over the Past 30 Years. Czech Part of the EUROASPIRE I-IV Surveys

Original language description

Cardiovascular (CV) mortality was reduced more than 50 % in the Czech population at the turn of the century, due to an improvement of major CV risk factors in the general population, interventional procedures implemented into the treatment of acute coronary events, and new drugs (ACE inhibitors, statins etc.) for CV prevention (Czech MONICA and post-MONICA studies, 1985-2008). An insufficient level of preventive efforts is described in the Czech patients after acute coronary syndrome (Czech part of the EUROASPIRE studies, 1995-2013). Drug underdosing and wrong patients&apos; compliance to life style and drug therapy recommendations represent two main reasons of this unsatisfactory situation. The residual vascular risk of patients with stable coronary heart disease (CHD) is still high due to a poor control of conventional risk factors on the one hand, and due to increasing weight and glucose metabolism abnormalities on the other hand. Patients with insulin resistance and glucose disorders have more frequently non-LDL-C dyslipidemia (atherogenic dyslipidemia), hypertriglyceridemic waist and high atherogenic index of plasma (AIP&gt;0.24), i.e. markers of residual CV risk. Among others increased dose of statins and combined lipid modifying therapy should be implemented in patients with CHD, diabetes or metabolic syndrome.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30201 - Cardiac and Cardiovascular systems

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2017

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Physiological Research

ISSN

0862-8408

e-ISSN

—

Volume of the periodical

66

Issue of the periodical within the volume

Supplement 1

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

8

Pages from-to

"S77"-"S84"

UT code for WoS article

000398620900009

EID of the result in the Scopus database

2-s2.0-85017183821